Timber Pharmaceuticals, Inc.
TMBR
TMBR was delisted on the 28th of November, 2023.
13 hedge funds and large institutions have $835K invested in Timber Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.
484% more capital invested
Capital invested by funds: $143K → $835K (+$692K)
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
86% more funds holding
Funds holding: 7 → 13 (+6)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
+$176K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$150K |
| 3 |
Jane Street
New York
|
+$77.9K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$50K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$44K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$186K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$13K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$7.92K |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CAN
1
Cetera Advisor Networks
El Segundo,
California
| $207K | +$176K | +2,043 | New |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $177K | +$150K | +1,741 | New |
|
|
BCM
3
Bridgeway Capital Management
Houston,
Texas
| $103K | -$186K | -2,156 | -68% |
|
|
4
Jane Street
New York
| $92K | +$77.9K | +905 | New |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| $58K | +$50K | +581 | New |
|
|
6
Citadel Advisors
Miami,
Florida
| $52K | +$44K | +511 | New |
|
7
Bank of New York Mellon
New York
| $49K | +$41.5K | +482 | New |
|
|
SFI
8
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
| $45K | +$38.6K | +448 | New |
|
|
RJFSA
9
Raymond James Financial Services Advisors
St. Petersburg,
Florida
| $30K | +$25.8K | +300 | New |
|
|
10
UBS Group
Zurich,
Switzerland
| $17K | -$7.92K | -92 | -35% |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $5K | +$3.79K | +44 | New |
|
|
TSS
12
Two Sigma Securities
New York
| – | -$13K | -352 | Closed |
|
|
ASN
13
Advisory Services Network
Atlanta,
Georgia
| – | -$2K | -60 | Closed |
|
TMBR Hedge Fund Activity: Q1 2021 in Review
13 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Timber Pharmaceuticals, Inc. (TMBR) for Q1 2021, worth a combined $835K — up 484% from $143K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new TMBR positions and 3 closed out — a net gain of 6 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Cetera Advisor Networks, opening a new position worth an estimated $176K. The largest seller was Bridgeway Capital Management, cutting an estimated $186K.
- 13 institutional investors held Timber Pharmaceuticals, Inc. (TMBR) as of Q1 2021, up from 7 in Q4 2020.
- Funds reported $835K of Timber Pharmaceuticals, Inc. stock for Q1 2021, up 484% quarter-over-quarter.
- 9 funds opened new Timber Pharmaceuticals, Inc. positions in Q1 2021 and 3 closed out, a net change of +6 holders.
- The largest Timber Pharmaceuticals, Inc. buyer in Q1 2021 was Cetera Advisor Networks, an estimated $176K added.
- The largest Timber Pharmaceuticals, Inc. seller in Q1 2021 was Bridgeway Capital Management, an estimated $186K sold.
Based on aggregated 13F filings for Q1 2021.